Fig. 6. PHI inhibited the inflammation of BMDMs by inhibiting
the NLRP3 inflammasome pathway. (A) The cell viability of BMDM with PHI
treatment. (B and C) The protein and gene expression levels in
LPS-induced BMDM. (D) The gene expression level of Nlrp3 and Caspase 1.
(E) The protein expression of inflammasome and its upstream pathway. (F)
Representative images of immunofluorescence staining of NLRP3, bar = 10
μm. Compared with the LPS or LPS&ATP-stimulated group *p <0.05,
**p <0.01, ***p <0.001, n = 3-4.